NUWE logo

NUWELLIS INC

NUWENASDAQ
๐Ÿ† #5187 by market capEarnings Mar 8US Equity
$3.41โ–ผ $0.40 (โˆ’10.50%)
Market closed ยท at close
๐Ÿ””
Track NUWE
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ผ 10.5%
7dโ–ผ 31.0%
14dโ–ผ 26.2%
30dโ–ฒ 13.2%
ytdโ–ผ 99.4%
1yโ–ผ 99.5%
๐ŸฆMarket Cap
$2M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
8.4%
Slowing
๐Ÿ“ŠGross Margin
69.7%
High
๐Ÿ’ตFCF Margin
โ€”
โš–๏ธP/S Ratio
0.2x
Cheap
Otter Score
โ€”
Insufficient data

Trading Snapshot

Day Range
$3.36 โ€“ $3.41
52-Week Range
$2.52 โ€“ $1,556.10
Volume (shares)
8,988
Avg Volume (shares)
โ€”
Shares Outstanding
540,000
Next Earnings
2027-03-08

Fundamentals Snapshot

Annual Revenue
$8M
Last Q Revenue
$2M
P/E Ratio
โ€”
P/S Ratio
0.2x
EPS (TTM)
$-1,382.26
Dividend Yield
โ€”
Dilution (1yr)
โˆ’52.1%
NUWE logo

NUWELLIS INC

NUWE
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$8Mโ–ผ โˆ’5.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
62.0%โ–ผ โˆ’7.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnโ€™t profitable yet.
โˆ’$11Mโ–ฒ +1.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
โˆ’$11Mโ–ฒ +12.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerโ€™s slice.
5Kโ–ผ โˆ’52.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$757Kโ–ผ โˆ’$4M YoY
StockOtter ยท stockotter.space

About NUWELLIS INC

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿ’งDilutionโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100
Analyst data unavailable.

Latest News & Updates

GlobeNewsWireยท3d ago

Nuwellis to Host Webinar Discussing ULTRA-Peds Registry Results and Aquadex Performance in Critically Ill Pediatric Patients

Live discussion will feature study investigators examining clinical findings, treatment outcomes, and the role of ultrafiltration in pediatric fluid management Live discussion will feature study investigators examining c

Seeking Alphaยท10d ago

Nuwellis, Inc. (NUWE) Q3 2026 Earnings Call Transcript

Nuwellis, Inc. (NUWE) Q3 2026 Earnings Call Transcript

GlobeNewsWireยท10d ago

Nuwellis Reports Third Quarter 2026 Financial Results and Business Update Highlighted by 430 Basis Point Gross Margin Expansion and 13% Reduction in Operating Expenses, Driving 24% Improvement in Operating Loss

Console unit sales increased 88% year-to-date versus prior-year period, expanding its installed base to drive future recurring circuit revenue Advanced growth strategy with 510(k) submission for Aquadex label expansion a

GlobeNewsWireยท12d ago

Nuwellis Secures Exclusive U.S. Distribution Rights for Zorro-Flowยฎ Pediatric Urine Collection System Supporting Non-invasive Urine Collection and Earlier Identification of Acute Kidney Injury in Neonates and Small Children

MINNEAPOLIS, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced that it has secured e

GlobeNewsWireยท17d ago

Nuwellis Submits FDA 510(k) to Expand Aquadex SmartFlowยฎ Indication to Include Pediatric Patients Weighing 5 kg and Above

Submission represents a significant regulatory milestone in advancing access to precision fluid management for smaller pediatric patients Submission represents a significant regulatory milestone in advancing access to pr

GlobeNewsWireยท18d ago

Nuwellis to Report Third Quarter 2026 Financial Results on November 12

MINNEAPOLIS, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces it will report financial re